Related Experiment Video
Updated: Jul 31, 2026
09:58
Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation
Published on: June 5, 2012
Management of echinococcosis
1Department of Gastroenterology, SMS Medical College and Hospital, Jaipur.
The Journal of the Association of Physicians of India
|August 17, 2006
Summary
Cystic echinococcosis, a parasitic infection from tapeworms transmitted by dogs, causes cysts in organs like the liver and lungs. Diagnosis uses imaging and serology, with treatment varying from medical to surgical approaches based on cyst type.
Area of Science:
- Zoonotic Diseases
- Parasitology
- Medical Imaging
Background:
- Cystic echinococcosis is a zoonotic disease caused by Echinococcus granulosus larval forms.
- The disease manifests as slow-growing cysts, primarily in the liver and lungs.
- Hepatic hydatid cysts present with symptoms like right upper quadrant pain and liver enlargement.
Purpose of the Study:
- To review the clinical presentation, diagnosis, and treatment of cystic echinococcosis.
- To highlight diagnostic modalities and therapeutic options for hepatic hydatid cysts.
- To differentiate treatment strategies for univesicular versus multivesicular/complicated cysts.
Main Methods:
- Review of clinical features associated with hepatic hydatid cysts.
- Emphasis on ultrasonography and serology as primary diagnostic tools.
- Discussion of treatment modalities including medical, percutaneous (PAIR), and surgical interventions.
Main Results:
- Ultrasonography combined with serology is the primary diagnostic method.
- Percutaneous treatment (PAIR) is effective and safe for univesicular cysts with infrequent complications.
- Surgery remains the primary treatment for multivesicular and complicated cysts.
Conclusions:
- Hepatic hydatid cysts require accurate diagnosis and tailored treatment.
- Percutaneous Aspiration-Injection-Aspiration (PAIR) offers a safe and effective minimally invasive option for uncomplicated cysts.
- Surgical intervention is essential for managing complex or multivesicular cystic echinococcosis.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...